Xalnesiran (sodium), CAS 2538784-49-3

Product Description: Xalnesiran (sodium) is siRNA for the treatment of chronic hepatitis B (HBV)..

Applications: COVID-19-anti-virus

Formula: C664H814F17N231Na57O415P57S6

References: [1]WHO Drug Information, Vol. 35, No. 4, 2021

CAS Number: 2538784-49-3

Molecular Weight: 22262.12

Compound Purity: 95.90

Research Area: Infection

Solubility: 10 mM in H2O

Target: HBV

• Artikelnummer: MEXHY-145638A-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-145638A-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK